Comparative in vitro activity of levofloxacin and ofloxacin against gram-positive bacteria

Diagnostic Microbiology and Infectious Disease

Volumn 25, Issue 1, 1996, Pages 35-41

  Eliopoulos, George M ^a   Wennersten, Christine B ^a   Moellering Jr , Robert C ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; ENTEROCOCCUS FAECALIS; GRAM POSITIVE BACTERIUM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; STREPTOCOCCUS;

EID: 0009507719     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/0732-8893(96)00069-7     Document Type: Article

References (9)

1. Barry A, Fuchs P, Tenover F, Allen S, Hardy D, Jorgensen J, McLaughlin J, Reller L (1994) Interpretative criteria and quality control for antimicrobial susceptibility tests of levofloxacin. Eur J Clin Microbiol Infect Dis 13:822-826.
2. Eliopoulos GM, Eliopoulos CT (1993) Activity in vitro of the quinolones. In Quinolone Antimicrobial Agents. Eds, DC Hooper and JS Wolfson. Washington, DC: American Society for Microbiology, pp 161-193.
3. Eliopoulos GM, Wennersten CB, Cole G, Moellering RC Jr (1995) In vitro activity of WY-49605, a penem antimicrobial. Int J Antimicrob Agents 5:251-257.
4. Fu KP, Lafredo SC, Foleno B, Isaacson DM, Barrett JF, Tobia AJ, Rosenthale ME (1992) In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin. Antimicrob Agents Chemother 36:860-866.
5. Hayakawa I, Atarashi S, Yokohama S, Imamura M, Sakano K-I, Furukawa M (1986) Synthesis and antibacterial activities of optically active ofloxacin. Antimicrob Agents Chemother 29:163-164.
6. National Committee for Clinical Laboratory Standards (NCCLS) (1993) Standard methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A3. Villanova, PA: NC-CLS.
7. National Committee for Clinical Laboratory Standards (NCCLS) (1995) Performance standards for antimicrobial susceptibility testing: sixth informational supplement. M100-S6. Villanova, PA: NCCLS.
8. Neu HC, Chin N-X (1989) In vitro activity of S-ofloxacin. Antimicrob Agents Chemother 33:1105-1107.
9. Une T, Fujimoto T, Sato K, Osada Y (1988) In vitro activity of DR-3355, an optically active ofloxacin. Antimicrob Agents Chemother 32:1336-1340.